- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Eledon Pharmaceuticals Inc (ELDN)
Eledon Pharmaceuticals Inc stock price live, this page displays NASDAQ ELDN stock exchange data. View the ELDN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Eledon Pharmaceuticals Inc real time stock price chart below.
What Is the Eledon Pharmaceuticals Inc Stock Price Today?
The Eledon Pharmaceuticals Inc stock price today is 3.700.
What Is the Stock Symbol for Eledon Pharmaceuticals Inc?
The stock symbol for Eledon Pharmaceuticals Inc is ""ELDN.""
What Stock Exchange Does Eledon Pharmaceuticals Inc Trade On?
Eledon Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Eledon Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Eledon Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ELDN quote. (ISIN: US28617K1016)
What Is the Eledon Pharmaceuticals Inc Stock Price Today?
The Eledon Pharmaceuticals Inc stock price today is 3.700.
What Is the Stock Symbol for Eledon Pharmaceuticals Inc?
The stock symbol for Eledon Pharmaceuticals Inc is ""ELDN.""
What Stock Exchange Does Eledon Pharmaceuticals Inc Trade On?
Eledon Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Eledon Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Eledon Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ELDN quote. (ISIN: US28617K1016)
NASDAQ
Currency in USD
3.700
-0.050(-1.33%)
Closed·
After Hours
3.852+0.152(+4.108%)
·
Fair Value
An estimate of a Eledon Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.640
3.830
52 wk Range
2.375
5.540
ELDN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ELDN is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Eledon Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.6403.830
52 wk Range
2.3755.540
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ELDN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Eledon Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
9.000
Upside
+143.24%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Eledon Pharmaceuticals Inc Company Profile
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for the prevention of allograft rejection in kidney transplantation and xenotransplantation. The company has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Compare ELDN to Peers and Sector
Metrics to compare | ELDN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipELDNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.6x | −5.0x | −0.5x | |
PEG Ratio | −0.13 | 0.02 | 0.00 | |
Price/Book | 1.9x | 3.8x | 2.6x | |
Price / LTM Sales | - | 246.9x | 3.2x | |
Upside (Analyst Target) | 143.2% | 133.6% | 44.6% | |
Fair Value Upside | Unlock | 5.2% | 6.5% | Unlock |
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 9.000
(+143.24% Upside)
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-0.08 / -0.25
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Eledon Pharmaceuticals Trade On?
Eledon Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Eledon Pharmaceuticals?
The stock symbol for Eledon Pharmaceuticals is "ELDN."
What Is the Eledon Pharmaceuticals Market Cap?
As of today, Eledon Pharmaceuticals market cap is 221.56M.
What Is Eledon Pharmaceuticals's Earnings Per Share (TTM)?
The Eledon Pharmaceuticals EPS (TTM) is -0.32.
When Is the Next Eledon Pharmaceuticals Earnings Date?
Eledon Pharmaceuticals will release its next earnings report on 06 Aug 2025.
From a Technical Analysis Perspective, Is ELDN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Eledon Pharmaceuticals Stock Split?
Eledon Pharmaceuticals has split 2 times.
How Many Employees Does Eledon Pharmaceuticals Have?
Eledon Pharmaceuticals has 31 employees.
What is the current trading status of Eledon Pharmaceuticals (ELDN)?
As of 19 Jul 2025, Eledon Pharmaceuticals (ELDN) is trading at a price of 3.70, with a previous close of 3.75. The stock has fluctuated within a day range of 3.64 to 3.83, while its 52-week range spans from 2.38 to 5.54.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.